Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential

Stem Cells Translational Medicine

Volumn 1, Issue 5, 2012, Pages 359-372

  Nazarov, Igor ^a   Lee, Jae W ^b   Soupene, Eric ^a   Etemad, Sara ^a   Knapik, Derrick ^a   Green, William ^a   Bashkirova, Elizaveta ^a   Fang, Xiaohui ^b   Matthay, Michael A ^b   Kuypers, Frans A ^a   Serikov, Vladimir B ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adult stem cells; Cytokines; Mesenchymal stem cells; Placenta; Telomerase

Indexed keywords

5' NUCLEOTIDASE; CHORIONIC GONADOTROPIN; ENDOGLIN; ESCHERICHIA COLI ENDOTOXIN; KERATINOCYTE GROWTH FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; SCATTER FACTOR; SMALL INTERFERING RNA; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; STEM CELL FACTOR RECEPTOR; TELOMERASE; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TERT PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENGRAFTMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID TRANSPORT; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG PERFUSION; MALE; MESENCHYMAL STEM CELL; MOUSE; MULTIPOTENT STEM CELL; NEWBORN; NONHUMAN; NORMAL HUMAN; PLACENTA; PLACENTA PERFUSION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING; Y CHROMOSOME; ANIMAL; CELL LINEAGE; CHORION; CYTOLOGY; ECTODERM; ENDODERM; GENETICS; LUNG ALVEOLUS; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE MUTANT; NEOPLASM; NONOBESE DIABETIC MOUSE; PREGNANCY; STEM CELL TRANSPLANTATION; TELOMERE;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHORION; ECTODERM; ENDODERM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MULTIPOTENT STEM CELLS; NEOPLASMS; PLACENTA; PREGNANCY; PULMONARY ALVEOLI; STEM CELL TRANSPLANTATION; TELOMERASE; TELOMERE;

EID: 84872118370     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2011-0021     Document Type: Article

References (34)

1. Serikov V, Hounshell C, Larkin S et al. Human term placenta as a source of hematopoietic cells. Exp Biol Med (Maywood) 2009;234:813-823.
2. Gekas C, Dieterlen-Lievre F, Orkin S et al. The placenta is a niche for hematopoietic stem cells. Dev Cell 2005;8:365-375.
3. Robin C, Bollerot K, Mendes S et al. Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 2009;5:385-395.
4. Bárcena A, Kapidzik M, Muench M et al. The human placenta is a hematopoietic organ during the embryonic and fetal periods of development. Dev Biol 2009;327:24-33.
5. Levi B, Morrison S. Stem cells use distinct self-renewal programs at different ages. Cold Spring Harb Symp Quant Biol 2008;73:539-553.
6. De Coppi P, Bartsch G, Siddiqui M et al. Isolation of amnionic stem cell lines with potential for therapy. Nat Biotechnol 2007;25:100-106.
7. Fukuchi Y, Nakagima H, Sugiyama D et al. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. STEM CELLS 2004;22:649-658.
8. Matikainen T, Laine J. Placenta: An alternative source of stem cells. Toxicol Appl Pharmacol 2005;207(2 suppl):544-549.
9. Yen BL, Huang HI, Chien CC et al. Isolation of multipotent cells from human term placenta. STEM CELLS 2005;23:3-9.
10. Sakuragawa N, Kakinuma K, Kikuchi A et al. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 2004;78:208-214.
11. In't Anker PS, Scherjon SA, Kleijburgvan der Keur C et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. STEM CELLS 2004;22: 1338-1345.
12. Portmann-Lanz C, Schoeberlein A, Huber A et al. Placental mesenchymal stem cells as potential autologous graft for preand perinatal neuroregeneration. Am J Obstet Gynecol 2006;194:664-673.
13. Wolbank S, Peterbauer A, Fahrner M et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007;13: 1173-1183.
14. Soncini M, Vertua E, Gibelli L et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 2007;1:296-305.
15. Wei J, Zhang T, Kawa S et al. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant 2003;12:545-552.
16. Alviano F, Fossati V, Marchionni C et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 2007;7:11.
17. Zhao P, Ise H, Hongo M et al. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005;79:528-535.
18. Parolini O, Alviano F, Bagnara G et al. Isolation and characterization of cells from human term placenta: Outcome of the First International workshop on placenta derived stem cells. STEM CELLS 2008;26:300-311.
19. Bailo M, Soncini M, Vertua E et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004;78:1439-1448.
20. Zhang X, Mitsuru A, Igura K et al. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 2006;340:944-952.
21. Serikov V, Choi H, Chmiel KJ et al. Activation of extracellular regulated kinases is required for the increase in airway epithelial permeability during leukocyte transmigration. Am J Respir Cell Mol Biol 2004;30:261-270.
22. Lee J, Xiaohui Fang, Gupta N et al. Potential application of mesenchymal stem cells in acute lung injury. Proc Natl Acad Sci USA 2009; 106:16357-16362.
23. Muntoni A, Reddel R. The first molecular details of ALT in human tumor cells. Hum Mol Genet 2005;14:R191-R196.
24. Poloni A, Rosini V, Mondini E et al. Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. Cytotherapy 2008;10: 690-697.
25. Castrechini N, Murthi P, Gude N et al. Mesenchymal stem cells in human placental chorionic villi reside in a vascular niche. Placenta 2010;31:203-212.
26. Portmann-Lanz CB, Baumann MU, Mueller M et al. Neurogenic characteristics of placental stem cells in preeclampsia. Am J Obstet Gynecol 2010;203:399.e1-e7.
27. Cargnoni A, Gibelli L, Tosini A et al. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 2009;18: 405-422.
28. Barlow S, Brooke G, Chatterjee K et al. Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 2008;176:1095-1107.
29. Semenov OV, Koestenbauer S, Riegel M et al. Multipotent mesenchymal stem cells from human placenta: Critical parameters for isolation and maintenance of stemness after isolation. Am J Obstet Gynecol 2010;2022: 193.e1-193.e13.
30. Crosby L, Waters C. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010;298:L715-L731.
31. Ware L, Matthay M. Keratinocyte and hepatocyte growth factors in the lung: Roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002;282: L924-L940.
32. Ferretti C, Bruni L, Dangles-Marie V. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capaciies of trophoblasts. Hum Reprod Update 2007;13:121-141.
33. Itoh N, Ornitz D. Fibroblast growth factors: From molecular evolution to roles in development, metabolism and disease. J Biochem 2011;149:121-130.
34. Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy. J Transl Med 2011;9:29-35.